Literature DB >> 16140432

The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun.

Jonathan Williman1, Euan Lockhart, Lynn Slobbe, Glenn Buchan, Margaret Baird.   

Abstract

Unlike intramuscular injection, gene gun delivery of DNA drives a strong type 2 response. In an effort to counter this, we have genetically fused the type 1 cytokines, IL-12 and IL-23, to the hemagglutinin (HA) gene from influenza APR/8/34, and delivered these DNA constructs to Balb/c mice. Gene gun delivery of the HA gene was able to induce antibody production by all vaccinated mice. Linking of IL-12 caused almost complete suppression of immune responses whereas mice vaccinated with IL-23HA showed long-lived IgG1 antibody levels. Splenocytes from IL-23HA vaccinated mice also tended to produce more IL-5 and IFNgamma after restimulation in vitro than splenocytes from HA vaccinated mice. While codelivery of IL-23 did not change the type of immune response it may increase its longevity following vaccination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140432     DOI: 10.1016/j.vaccine.2005.08.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  Th17 cytokines and vaccine-induced immunity.

Authors:  Yinyao Lin; Samantha R Slight; Shabaana A Khader
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

2.  The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert.

Authors:  Katarina Radosevic; Ariane Rodriguez; Angelique A C Lemckert; Marjolein van der Meer; Gert Gillissen; Carolien Warnar; Rie von Eyben; Maria Grazia Pau; Jaap Goudsmit
Journal:  Clin Vaccine Immunol       Date:  2010-09-08

Review 3.  Immunogenetics of seasonal influenza vaccine response.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

4.  Intranasal administration of poly-gamma glutamate induced antiviral activity and protective immune responses against H1N1 influenza A virus infection.

Authors:  Eun-Ha Kim; Young-Ki Choi; Chul-Joong Kim; Moon-Hee Sung; Haryoung Poo
Journal:  Virol J       Date:  2015-10-06       Impact factor: 4.099

5.  Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.

Authors:  Bo Peng; Na Peng; Yanan Zhang; Fenghua Zhang; Xuguang Li; Haiyan Chang; Fang Fang; Fuyan Wang; Fangguo Lu; Ze Chen
Journal:  Front Immunol       Date:  2017-08-31       Impact factor: 7.561

6.  Immune response to dna vaccine expressing transferrin binding protein a gene of Pasteurella multocida.

Authors:  Satparkash Singh; Vijendra Pal Singh; Pawanjit Singh Cheema; Maninder Sandey; Rajeev Ranjan; Santosh Kumar Gupta; Bhaskar Sharma
Journal:  Braz J Microbiol       Date:  2011-06-01       Impact factor: 2.476

7.  Intranasal vaccination promotes detrimental Th17-mediated immunity against influenza infection.

Authors:  Asher Maroof; Yvonne M Yorgensen; Yufeng Li; Jay T Evans
Journal:  PLoS Pathog       Date:  2014-01-23       Impact factor: 6.823

8.  Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection.

Authors:  Inga Ohs; Sonja Windmann; Oliver Wildner; Ulf Dittmer; Wibke Bayer
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.